196 related articles for article (PubMed ID: 25511524)
1. Insulin resistance as a therapeutic target for chronic kidney disease.
Teta D
J Ren Nutr; 2015 Mar; 25(2):226-9. PubMed ID: 25511524
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance in chronic kidney disease: a systematic review.
Spoto B; Pisano A; Zoccali C
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1087-F1108. PubMed ID: 27707707
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in chronic kidney disease: new lessons from experimental models.
Koppe L; Pelletier CC; Alix PM; Kalbacher E; Fouque D; Soulage CO; Guebre-Egziabher F
Nephrol Dial Transplant; 2014 Sep; 29(9):1666-74. PubMed ID: 24286973
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.
Chan DT; Watts GF; Irish AB; Ooi EM; Dogra GK
Am J Hypertens; 2013 Sep; 26(9):1155-61. PubMed ID: 23736110
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance in chronic kidney disease.
Xu H; Carrero JJ
Nephrology (Carlton); 2017 Dec; 22 Suppl 4():31-34. PubMed ID: 29155496
[TBL] [Abstract][Full Text] [Related]
6. Contribution of uremic dysbiosis to insulin resistance and sarcopenia.
Uchiyama K; Wakino S; Irie J; Miyamoto J; Matsui A; Tajima T; Itoh T; Oshima Y; Yoshifuji A; Kimura I; Itoh H
Nephrol Dial Transplant; 2020 Sep; 35(9):1501-1517. PubMed ID: 32535631
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenesis and treatment of insulin resistance in chronic kidney disease and interventional effects of Chinese herbal medicine].
Wu W; Yang JJ; Wan YG; Tu Y; Shi G; Han WB; Liu BH; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(1):49-55. PubMed ID: 28945024
[TBL] [Abstract][Full Text] [Related]
8. Role of Vitamin D in Uremic Vascular Calcification.
Hou YC; Liu WC; Zheng CM; Zheng JQ; Yen TH; Lu KC
Biomed Res Int; 2017; 2017():2803579. PubMed ID: 28286758
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
[TBL] [Abstract][Full Text] [Related]
10. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health.
Tomey MI; Winston JA
Ann Glob Health; 2014; 80(1):69-76. PubMed ID: 24751567
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions.
Chan DT; Watts GF; Irish AB; Dogra GK
Nephrol Dial Transplant; 2017 Aug; 32(8):1274-1281. PubMed ID: 26374599
[TBL] [Abstract][Full Text] [Related]
13. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
Chalmers L; Kaskel FJ; Bamgbola O
Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
[TBL] [Abstract][Full Text] [Related]
14. [Insulin resistance and chronic kidney disease].
Chauveau P; Rigalleau V; Aparicio M
Nephrol Ther; 2008 Dec; 4(7):568-74. PubMed ID: 18514051
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in chronic uremia.
Guarnieri G; Zanetti M; Vinci P; Cattin MR; Barazzoni R
J Ren Nutr; 2009 Jan; 19(1):20-4. PubMed ID: 19121765
[TBL] [Abstract][Full Text] [Related]
16. Metabonomic Profiling Reveals Difference in Altered Metabolic Pathways Between Chronic Kidney Disease and High-Fat-Induced Insulin Resistance in Rats.
Xu Z; Zhang L; Li J; Zhao Y; Chen X
Kidney Blood Press Res; 2018; 43(4):1199-1211. PubMed ID: 30071523
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly.
Cheng HT; Huang JW; Chiang CK; Yen CJ; Hung KY; Wu KD
J Clin Endocrinol Metab; 2012 Apr; 97(4):1268-76. PubMed ID: 22337909
[TBL] [Abstract][Full Text] [Related]
18. Endocrine alterations and cardiovascular risk in CKD: is there a link?
Ros S; Carrero JJ
Nefrologia; 2013; 33(2):181-7. PubMed ID: 23511754
[TBL] [Abstract][Full Text] [Related]
19. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies.
Hamed SA
Expert Rev Clin Pharmacol; 2019 Jan; 12(1):61-90. PubMed ID: 30501441
[No Abstract] [Full Text] [Related]
20. Effects of phosphate on vascular function under normal conditions and influence of the uraemic state.
Six I; Maizel J; Barreto FC; Rangrez AY; Dupont S; Slama M; Tribouilloy C; Choukroun G; Mazière JC; Bode-Boeger S; Kielstein JT; Drüeke TB; Massy ZA
Cardiovasc Res; 2012 Oct; 96(1):130-9. PubMed ID: 22822101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
